Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation

被引:13
作者
Vivo, C
Lecomte, C
Levy, F
Leroy, K
Kirova, Y
Renier, A
Kheuang, L
Piedbois, P
Chopin, D
Jaurand, MC
机构
[1] Univ Paris 12, INSERM, EMI 9909, Fac Med, F-94010 Creteil, France
[2] Hop Henri Mondor, Dept Pathol, EA 2348, F-94010 Creteil, France
[3] Hop Henri Mondor, Serv Oncol, AP HP, F-94010 Creteil, France
关键词
mesothelioma cells; cell cycle arrest; gamma-radiation;
D O I
10.1038/sj.bjc.6600736
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is generally not mutated, but may be inactivated by SV40 early region T antigen (SV40 Tag). However, the function of p53 has not been investigated in mesothelioma cells. Here, we investigated the function of the cell cycle checkpoints in six human mesothelioma cell lines (HMCLs) by studying the cell distribution in the different phases of the cell cycle by flow cytometry, and expression of cell cycle proteins, p53, p21(WAF1/CIP1) and p27(KIP1). In addition, we studied p53 gene mutations and expression of SV40 Tag. After exposure to x-radiation, HMCLs were arrested either in one or both phases of the cell cycle, demonstrating a heterogeneity in cell cycle control. GI arrest was p21(WAF1/CIP1) - and p53-dependent. Lack of arrest in G I was not related to p53 mutation or binding to SV40 Tag, except in one HMCL presenting a missense mutation at codon 248. These results may help us to understand mesothelioma and develop new treatments. (C) 2003 Cancer Research UK.
引用
收藏
页码:388 / 395
页数:8
相关论文
共 36 条
  • [1] The p53 network
    Agarwal, ML
    Taylor, WR
    Chernov, MV
    Chernova, OB
    Stark, GR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 1 - 4
  • [2] Stress signals utilize multiple pathways to stabilize p53
    Ashcroft, M
    Taya, Y
    Vousden, KH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) : 3224 - 3233
  • [3] Banaei A, 2000, OCCUP ENVIRON MED, V57, P488, DOI 10.1136/oem.57.7.488
  • [4] Blagosklonny MV, 2001, CANCER RES, V61, P4301
  • [5] Hypophosphorylation of Mdm2 augments p53 stability
    Blattner, C
    Hay, T
    Meek, DW
    Lane, DP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (17) : 6170 - 6182
  • [6] Buard A, 1998, CANCER RES, V58, P840
  • [7] Disruption of p53 in human cancer cells alters the responses to therapeutic agents
    Bunz, F
    Hwang, PM
    Torrance, C
    Waldman, T
    Zhang, YG
    Dillehay, L
    Williams, J
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) : 263 - 269
  • [8] Requirement for p53 and p21 to sustain G2 arrest after DNA damage
    Bunz, F
    Dutriaux, A
    Lengauer, C
    Waldman, T
    Zhou, S
    Brown, JP
    Sedivy, JM
    Kinzler, KW
    Vogelstein, B
    [J]. SCIENCE, 1998, 282 (5393) : 1497 - 1501
  • [9] Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma
    Cao, XBX
    Mohuiddin, I
    Ece, F
    McConkey, DJ
    Smythe, WR
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (05) : 562 - 568
  • [10] CARBONE M, 1994, ONCOGENE, V9, P1781